Indivior Pharmaceuticals, Inc. (INDV)

34.94 +0.11 (+0.32%) USD  |  NASDAQ  |  Sep 04, 16:00
34.93 -0.01 (-0.03%) After-Hours: 20:00
More

Indivior Pharmaceuticals SG&A Expense (TTM) : 591.00M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for INDV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 591.00M
March 31, 2026 627.00M
December 31, 2025 635.00M
September 30, 2025 623.00M
June 30, 2025 675.00M
March 31, 2025 828.00M
December 31, 2024 841.00M
September 30, 2024 821.00M
June 30, 2024 1.003B
March 31, 2024 825.00M
December 31, 2023 811.00M
September 30, 2023 1.086B
June 30, 2023 811.00M
March 31, 2023 787.00M
December 31, 2022 765.00M
September 30, 2022 402.00M
June 30, 2022 345.00M
March 31, 2022 277.00M
December 31, 2021 210.00M
September 30, 2021 242.00M
June 30, 2021 241.00M
March 31, 2021 259.00M
December 31, 2020 446.00M
Date Value
September 30, 2020 385.00M
June 30, 2020 376.00M
March 31, 2020 404.00M
December 31, 2019 289.00M
September 30, 2019 389.00M
June 30, 2019 464.00M
March 31, 2019 508.00M
December 31, 2018 493.00M
September 30, 2018 679.00M
June 30, 2018 718.00M
March 31, 2018 714.00M
December 31, 2017 708.00M
September 30, 2017 507.00M
June 30, 2017 679.00M
March 31, 2017 667.00M
December 31, 2016 678.00M
September 30, 2016 654.00M
June 30, 2016 427.00M
March 31, 2016 400.00M
December 31, 2015 379.00M
September 30, 2015 278.00M
June 30, 2015 171.00M
March 31, 2015 83.00M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Supernus Pharmaceuticals, Inc. 560.88M
Liquidia Corp. 192.66M
Corcept Therapeutics, Inc. 556.47M
Harrow, Inc. 175.69M
Collegium Pharmaceutical, Inc. 327.69M